These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26644039)

  • 41. Pneumocystis carinii pneumonia in patients without HIV infection.
    Russian DA; Levine SJ
    Am J Med Sci; 2001 Jan; 321(1):56-65. PubMed ID: 11202481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pneumocystis carinii pneumonia among patients with neoplastic disease.
    Sepkowitz KA
    Semin Respir Infect; 1992 Jun; 7(2):114-21. PubMed ID: 1439321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of dihydropteroate synthase mutants in HIV-infected South African children with Pneumocystis jiroveci pneumonia.
    Zar HJ; Alvarez-Martinez MJ; Harrison A; Meshnick SR
    Clin Infect Dis; 2004 Oct; 39(7):1047-51. PubMed ID: 15472859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extrapulmonary pneumocystosis.
    Ng VL; Yajko DM; Hadley WK
    Clin Microbiol Rev; 1997 Jul; 10(3):401-18. PubMed ID: 9227859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [AIDS patient with pneumocystosis and pulmonary alveolar proteinosis].
    Crişan A; Tudorache V; Nicoară E; Laza R
    Pneumologia; 2009; 58(2):121-4. PubMed ID: 19637766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pneumocystis carinii pneumonia in human immunodeficiency virus-infected infants and children.
    Goodwin SD
    Pharmacotherapy; 1993; 13(6):640-6. PubMed ID: 8302691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advances in the treatment and prophylaxis of Pneumocystis carinii pneumonia.
    Warren E; George S; You J; Kazanjian P
    Pharmacotherapy; 1997; 17(5):900-16. PubMed ID: 9324180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Bender MA; Sax PE
    N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
    [No Abstract]   [Full Text] [Related]  

  • 49. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients.
    Roblot F; Godet C; Le Moal G; Garo B; Faouzi Souala M; Dary M; De Gentile L; Gandji JA; Guimard Y; Lacroix C; Roblot P; Becq-Giraudon B
    Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):523-31. PubMed ID: 12172743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Outstanding issues on pulmonary pneumocystosis among HIV negative patients].
    Bouguerba A; Ayed S; Roux A; Bornstain C; Vincent F;
    Rev Mal Respir; 2016 Jun; 33(6):555-7. PubMed ID: 27161753
    [No Abstract]   [Full Text] [Related]  

  • 51. Pneumocystis jiroveci pneumonia in inflammatory bowel disease: when should prophylaxis be considered?
    Okafor PN; Nunes DP; Farraye FA
    Inflamm Bowel Dis; 2013 Jul; 19(8):1764-71. PubMed ID: 23615530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment].
    González-García J; Rubio García R; Antela López A; García Alcaide F
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():36-44. PubMed ID: 9859618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of Sulfamethoxazole-Trimethoprim on Airway Colonization with Pneumocystis jirovecii.
    Kushima H; Ishii H; Tokimatsu I; Umeki K; Sato T; Kadota J
    Jpn J Infect Dis; 2016 May; 69(3):252-5. PubMed ID: 26255727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pneumocystis carinii pneumonia with pleural effusion in a non-HIV host.
    Balasubramanian VP; Komorowski RA; Santo Tomas LH
    WMJ; 2006 Jan; 105(1):62-5. PubMed ID: 16676494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.
    Safrin S
    Semin Respir Infect; 1993 Jun; 8(2):96-103. PubMed ID: 8278684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
    Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
    N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Consensus conference: pneumocystosis in HIV infections. 1st consensus conference in anti-infection therapeutics organized by "la Société de Pathologie Infectieuse de langue française", May 11, 1990].
    Rev Pneumol Clin; 1990; 46(3):132-5. PubMed ID: 2237149
    [No Abstract]   [Full Text] [Related]  

  • 59. Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention.
    Sowden E; Carmichael AJ
    BMC Infect Dis; 2004 Oct; 4():42. PubMed ID: 15488151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia.
    Madden RM; Pui CH; Hughes WT; Flynn PM; Leung W
    Cancer; 2007 Apr; 109(8):1654-8. PubMed ID: 17345613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.